Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RX4 | Q99571 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | ACHE | P22303 | 1/20 | 0.36 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.35 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.35 |
| ▸ | MAOA | P21397 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3991990 | 0.87 | ACHE (0.41) | P2RX4MEN1KMT2ANPC1POLB | |
| SCHEMBL3987042 | 0.86 | USP2 (0.46) | P2RX4MEN1KMT2ANPC1RAB9A | |
| SCHEMBL13395039 | 0.85 | OPRM1 (0.45) | P2RX4OPRM1OPRD1 | |
| SCHEMBL3173143 | 0.85 | OPRM1 (0.45) | P2RX4OPRM1OPRD1 | |
| SCHEMBL13394996 | 0.85 | OPRM1 (0.45) | P2RX4OPRM1OPRD1 | |
| SCHEMBL3984341 | 0.85 | OPRM1 (0.43) | OPRM1OPRD1 | |
| SCHEMBL3986089 | 0.83 | OPRM1 (0.42) | P2RX4MEN1KMT2APOLBACHE | |
| SCHEMBL3986087 | 0.83 | OPRK1 (0.42) | P2RX4MEN1KMT2ANPC1POLB | |
| SCHEMBL3994605 | 0.83 | USP2 (0.37) | P2RX4MEN1KMT2ANPC1POLB | |
| SCHEMBL3987816 | 0.82 | P2RX4 (0.41) | P2RX4MEN1KMT2ANPC1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1833826-B1 | TRICYCLIC DELTA-OPIOID MODULATORS | JANSSEN PHARMACEUTICA NV (BE) | 2009-05-27 | — | — | EP | claimed |